FDA Exploring ‘Flexibilities’ In Marijuana Scheduling Review, But Top Official Says DEA Has ‘Final Word’

Marijuana Moment
By Kyle JaegerOct 27, 2022, 7:26 pm259 pts
A top Food and Drug Administration (FDA) official said on Thursday that the agency is exploring “what flexibilities we might have” when it comes the federal government’s marijuana scheduling review directed by President Joe Biden, which she described as a “very high priority.” But she said that while…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Delaware Governor Seeks Marijuana Regulation Advice From Colorado Counterpart As State’s Legal Market Launches 75

Psilocybin Can ‘Maximize’ Recovery From Traumatic Brain Injury, Scientific Review Concludes 70

The Cannabist Co. Divests Dispensary Footprint in Pennsylvania 66

Mass. marijuana testing lab at center of scandal will reopen after $300K fine 65

Canopy USA Appoints New Executive Team to Accelerate Growth 62

Washington Adult-Use Cannabis Sales Decline for Fifth Straight Year 58

Rubicon Organics records its highest net revenue in Q2 2025 57

Massachusetts Auditor Notes ‘Violations’ and ‘Mismanagement’ At Cannabis Control Commission 56

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.